Socioeconomic Disadvantages Explain Maternal Age and ADHD Causal Association
Researchers examined the relationship between maternal age and childhood ADHD to determine which factors may mediate or confound the association.
Diagnosis & Disease Information
Experiencing Racism Tied to Doubled Odds of Depression During Pregnancy
Authors say respectful maternity care may help address maternal morbidity in Black women.
When Should Patients With GERD Seek a Mental Health Care Professional?
Individuals with gastroesophageal reflux disease have a higher prevalence of psychiatric disorders, which calls for a multidisciplinary approach to treatment.
Anxiety and Depression Association in Patients With Pediatric Psoriasis
Investigators sought to elucidate the prevalence of anxiety and depression in patients with pediatric psoriasis and advocate for psychological screening and intervention as needed.
Factors Linked to Pediatric Mental Health Emergency Revisits Identified
Psychiatric comorbidities, chemical restraint use, public insurance tied to emergency revisits; substance use disorders associated with lower likelihood of revisits.
Smartphone App May Be Beneficial for Some With Bipolar Disorder
Does not reduce risk of relapse overall, but can reduce relapse risk and manic symptom severity for low-risk individuals.
AAP Releases “Choosing Wisely” Recommendations for Pediatric Emergency Medicine
The AAP outlines 5 tests and procedures commonly ordered in pediatric emergency medicine that clinicians and patients should question.
Sustained Attention and White Matter Comparison Consistent in ADHD
Researchers sought to evaluate how sustained attention relates to white matter maturation in children who are neurotypical and children with ADHD.
Methylphenidate Improves Functionality in Preschoolers With ADHD
Researchers investigated the efficacy of methylphenidate and behavioral parent training in improving global functioning in preschool children with attention-deficit/hyperactivity disorder.
Esketamine Nasal Spray Bests Quetiapine XR in Difficult-to-Treat Depression
The trial compared Spravato (esketamine nasal spray) in the treatment of depression to quetiapine extended-release, both in combination with a continuing SSRI or SNRI.
- Loading...
Loading...
Next post in News
Loading... 
Loading...